世界の重症筋無力症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Myasthenia Gravis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3986 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、重症筋無力症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・重症筋無力症治療の市場動向 ・企業の競争状況、市場シェア ・重症筋無力症治療の種類別市場規模（薬物治療、手術） ・重症筋無力症治療の用途別市場規模（病院、診療所、その他） ・重症筋無力症治療の北米市場規模2016-2027（アメリカ、カナダ） ・重症筋無力症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・重症筋無力症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・重症筋無力症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・重症筋無力症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alexion Pharmaceutical Inc.、Grifols SA、Avadel Pharmaceuticals plc.、Novartis AG、Pfizer; Inc.、AbbVie Inc.、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Bausch Health Companies Inc.、Shire plc.） ・結論

Market Analysis and Insights: Global Myasthenia Gravis Treatment Market
The global Myasthenia Gravis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Myasthenia Gravis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Myasthenia Gravis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Myasthenia Gravis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Myasthenia Gravis Treatment market.

Global Myasthenia Gravis Treatment Scope and Market Size
Myasthenia Gravis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Myasthenia Gravis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medication
Surgery

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alexion Pharmaceutical Inc.
Grifols SA
Avadel Pharmaceuticals plc.
Novartis AG
Pfizer; Inc.
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Bausch Health Companies Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Myasthenia Gravis Treatment Market Perspective (2016-2027)
2.2 Myasthenia Gravis Treatment Growth Trends by Regions
2.2.1 Myasthenia Gravis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Myasthenia Gravis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Myasthenia Gravis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Myasthenia Gravis Treatment Industry Dynamic
2.3.1 Myasthenia Gravis Treatment Market Trends
2.3.2 Myasthenia Gravis Treatment Market Drivers
2.3.3 Myasthenia Gravis Treatment Market Challenges
2.3.4 Myasthenia Gravis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis Treatment Players by Revenue
3.1.1 Global Top Myasthenia Gravis Treatment Players by Revenue (2016-2021)
3.1.2 Global Myasthenia Gravis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Myasthenia Gravis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Myasthenia Gravis Treatment Revenue
3.4 Global Myasthenia Gravis Treatment Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Treatment Revenue in 2020
3.5 Myasthenia Gravis Treatment Key Players Head office and Area Served
3.6 Key Players Myasthenia Gravis Treatment Product Solution and Service
3.7 Date of Enter into Myasthenia Gravis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Myasthenia Gravis Treatment Breakdown Data by Type
4.1 Global Myasthenia Gravis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2022-2027)

5 Myasthenia Gravis Treatment Breakdown Data by Application
5.1 Global Myasthenia Gravis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Myasthenia Gravis Treatment Market Size (2016-2027)
6.2 North America Myasthenia Gravis Treatment Market Size by Type
6.2.1 North America Myasthenia Gravis Treatment Market Size by Type (2016-2021)
6.2.2 North America Myasthenia Gravis Treatment Market Size by Type (2022-2027)
6.2.3 North America Myasthenia Gravis Treatment Market Size by Type (2016-2027)
6.3 North America Myasthenia Gravis Treatment Market Size by Application
6.3.1 North America Myasthenia Gravis Treatment Market Size by Application (2016-2021)
6.3.2 North America Myasthenia Gravis Treatment Market Size by Application (2022-2027)
6.3.3 North America Myasthenia Gravis Treatment Market Size by Application (2016-2027)
6.4 North America Myasthenia Gravis Treatment Market Size by Country
6.4.1 North America Myasthenia Gravis Treatment Market Size by Country (2016-2021)
6.4.2 North America Myasthenia Gravis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Myasthenia Gravis Treatment Market Size (2016-2027)
7.2 Europe Myasthenia Gravis Treatment Market Size by Type
7.2.1 Europe Myasthenia Gravis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Myasthenia Gravis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Myasthenia Gravis Treatment Market Size by Type (2016-2027)
7.3 Europe Myasthenia Gravis Treatment Market Size by Application
7.3.1 Europe Myasthenia Gravis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Myasthenia Gravis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Myasthenia Gravis Treatment Market Size by Application (2016-2027)
7.4 Europe Myasthenia Gravis Treatment Market Size by Country
7.4.1 Europe Myasthenia Gravis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Myasthenia Gravis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type
8.2.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application
8.3.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region
8.4.1 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Myasthenia Gravis Treatment Market Size (2016-2027)
9.2 Latin America Myasthenia Gravis Treatment Market Size by Type
9.2.1 Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Myasthenia Gravis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2027)
9.3 Latin America Myasthenia Gravis Treatment Market Size by Application
9.3.1 Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Myasthenia Gravis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2027)
9.4 Latin America Myasthenia Gravis Treatment Market Size by Country
9.4.1 Latin America Myasthenia Gravis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Myasthenia Gravis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type
10.2.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application
10.3.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country
10.4.1 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alexion Pharmaceutical Inc.
11.1.1 Alexion Pharmaceutical Inc. Company Details
11.1.2 Alexion Pharmaceutical Inc. Business Overview
11.1.3 Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Introduction
11.1.4 Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.1.5 Alexion Pharmaceutical Inc. Recent Development
11.2 Grifols SA
11.2.1 Grifols SA Company Details
11.2.2 Grifols SA Business Overview
11.2.3 Grifols SA Myasthenia Gravis Treatment Introduction
11.2.4 Grifols SA Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.2.5 Grifols SA Recent Development
11.3 Avadel Pharmaceuticals plc.
11.3.1 Avadel Pharmaceuticals plc. Company Details
11.3.2 Avadel Pharmaceuticals plc. Business Overview
11.3.3 Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Introduction
11.3.4 Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.3.5 Avadel Pharmaceuticals plc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Myasthenia Gravis Treatment Introduction
11.4.4 Novartis AG Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Pfizer; Inc.
11.5.1 Pfizer; Inc. Company Details
11.5.2 Pfizer; Inc. Business Overview
11.5.3 Pfizer; Inc. Myasthenia Gravis Treatment Introduction
11.5.4 Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.5.5 Pfizer; Inc. Recent Development
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Myasthenia Gravis Treatment Introduction
11.6.4 AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.6.5 AbbVie Inc. Recent Development
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Details
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Development
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Company Details
11.8.2 GlaxoSmithKline plc Business Overview
11.8.3 GlaxoSmithKline plc Myasthenia Gravis Treatment Introduction
11.8.4 GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline plc Recent Development
11.9 Bausch Health Companies Inc.
11.9.1 Bausch Health Companies Inc. Company Details
11.9.2 Bausch Health Companies Inc. Business Overview
11.9.3 Bausch Health Companies Inc. Myasthenia Gravis Treatment Introduction
11.9.4 Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.9.5 Bausch Health Companies Inc. Recent Development
11.10 Shire plc.
11.10.1 Shire plc. Company Details
11.10.2 Shire plc. Business Overview
11.10.3 Shire plc. Myasthenia Gravis Treatment Introduction
11.10.4 Shire plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021)
11.10.5 Shire plc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Myasthenia Gravis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Surgery
Table 4. Global Myasthenia Gravis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Myasthenia Gravis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Myasthenia Gravis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Myasthenia Gravis Treatment Market Share by Regions (2016-2021)
Table 8. Global Myasthenia Gravis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Myasthenia Gravis Treatment Market Share by Regions (2022-2027)
Table 10. Myasthenia Gravis Treatment Market Trends
Table 11. Myasthenia Gravis Treatment Market Drivers
Table 12. Myasthenia Gravis Treatment Market Challenges
Table 13. Myasthenia Gravis Treatment Market Restraints
Table 14. Global Myasthenia Gravis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Myasthenia Gravis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Myasthenia Gravis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis Treatment as of 2020)
Table 17. Ranking of Global Top Myasthenia Gravis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Myasthenia Gravis Treatment Product Solution and Service
Table 21. Date of Enter into Myasthenia Gravis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Myasthenia Gravis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Myasthenia Gravis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Myasthenia Gravis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Myasthenia Gravis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Myasthenia Gravis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Myasthenia Gravis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Myasthenia Gravis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Myasthenia Gravis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Myasthenia Gravis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Alexion Pharmaceutical Inc. Company Details
Table 62. Alexion Pharmaceutical Inc. Business Overview
Table 63. Alexion Pharmaceutical Inc. Myasthenia Gravis Treatment Product
Table 64. Alexion Pharmaceutical Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 65. Alexion Pharmaceutical Inc. Recent Development
Table 66. Grifols SA Company Details
Table 67. Grifols SA Business Overview
Table 68. Grifols SA Myasthenia Gravis Treatment Product
Table 69. Grifols SA Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 70. Grifols SA Recent Development
Table 71. Avadel Pharmaceuticals plc. Company Details
Table 72. Avadel Pharmaceuticals plc. Business Overview
Table 73. Avadel Pharmaceuticals plc. Myasthenia Gravis Treatment Product
Table 74. Avadel Pharmaceuticals plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 75. Avadel Pharmaceuticals plc. Recent Development
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Myasthenia Gravis Treatment Product
Table 79. Novartis AG Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 80. Novartis AG Recent Development
Table 81. Pfizer; Inc. Company Details
Table 82. Pfizer; Inc. Business Overview
Table 83. Pfizer; Inc. Myasthenia Gravis Treatment Product
Table 84. Pfizer; Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 85. Pfizer; Inc. Recent Development
Table 86. AbbVie Inc. Company Details
Table 87. AbbVie Inc. Business Overview
Table 88. AbbVie Inc. Myasthenia Gravis Treatment Product
Table 89. AbbVie Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 90. AbbVie Inc. Recent Development
Table 91. F. Hoffmann-La Roche Ltd. Company Details
Table 92. F. Hoffmann-La Roche Ltd. Business Overview
Table 93. F. Hoffmann-La Roche Ltd. Myasthenia Gravis Treatment Product
Table 94. F. Hoffmann-La Roche Ltd. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 95. F. Hoffmann-La Roche Ltd. Recent Development
Table 96. GlaxoSmithKline plc Company Details
Table 97. GlaxoSmithKline plc Business Overview
Table 98. GlaxoSmithKline plc Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 99. GlaxoSmithKline plc Recent Development
Table 100. Bausch Health Companies Inc. Company Details
Table 101. Bausch Health Companies Inc. Business Overview
Table 102. Bausch Health Companies Inc. Myasthenia Gravis Treatment Product
Table 103. Bausch Health Companies Inc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 104. Bausch Health Companies Inc. Recent Development
Table 105. Shire plc. Company Details
Table 106. Shire plc. Business Overview
Table 107. Shire plc. Myasthenia Gravis Treatment Product
Table 108. Shire plc. Revenue in Myasthenia Gravis Treatment Business (2016-2021) & (US$ Million)
Table 109. Shire plc. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myasthenia Gravis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Surgery Features
Figure 4. Global Myasthenia Gravis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Myasthenia Gravis Treatment Report Years Considered
Figure 9. Global Myasthenia Gravis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Myasthenia Gravis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Myasthenia Gravis Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Myasthenia Gravis Treatment Market Share by Regions (2022-2027)
Figure 13. Global Myasthenia Gravis Treatment Market Share by Players in 2020
Figure 14. Global Top Myasthenia Gravis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Myasthenia Gravis Treatment Revenue in 2020
Figure 16. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Myasthenia Gravis Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Myasthenia Gravis Treatment Market Share by Type (2016-2027)
Figure 20. North America Myasthenia Gravis Treatment Market Share by Application (2016-2027)
Figure 21. North America Myasthenia Gravis Treatment Market Share by Country (2016-2027)
Figure 22. United States Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Myasthenia Gravis Treatment Market Share by Type (2016-2027)
Figure 26. Europe Myasthenia Gravis Treatment Market Share by Application (2016-2027)
Figure 27. Europe Myasthenia Gravis Treatment Market Share by Country (2016-2027)
Figure 28. Germany Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Myasthenia Gravis Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Myasthenia Gravis Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Myasthenia Gravis Treatment Market Share by Region (2016-2027)
Figure 38. China Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Myasthenia Gravis Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Myasthenia Gravis Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Myasthenia Gravis Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Myasthenia Gravis Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Myasthenia Gravis Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Myasthenia Gravis Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Myasthenia Gravis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Alexion Pharmaceutical Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 58. Grifols SA Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 59. Avadel Pharmaceuticals plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 61. Pfizer; Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 62. AbbVie Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 64. GlaxoSmithKline plc Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 65. Bausch Health Companies Inc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 66. Shire plc. Revenue Growth Rate in Myasthenia Gravis Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---